Press Release: ADAMA Provides Financial Performance Estimation for the First Half of 2025

Dow Jones
07/14

TEL AVIV, Israel and BEIJING, July 14, 2025 /PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE: 000553), today provided an estimate regarding its financial performance for the first half of 2025. The Company saw further positive impact of its 'Fight Forward' strategic transformation plan, with improvements in key financial metrics.

Sales

Supported by the growth of revenues in the second quarter of 2025, ADAMA is expecting to report flat sales for the first half of 2025 (0% in USD, 1% in RMB), compared to the first half of 2024. The stabilization of revenues in H1 2025 was driven by volume growth due to improved channel inventories, which offset lower prices. Prices were weak mainly due to low prices of active ingredients in light of overcapacity, as well as a higher interest rate environment and comparably low commodity prices, which put pressure on distributors and farmers.

Adjusted EBITDA and Net Profit

For the first half of 2025, the Company is expecting to report an increase in adjusted EBITDA and in its margin, in comparison to the first half of 2024. Adjusted EBITDA and its margin improved due to an increase in the gross profit and its margin, mainly reflecting the positive impact of lower costs of new inventory sold and higher volumes.

The Company expects to report an adjusted net profit in the range of USD 47 million to 54 million for the first half of 2025, compared to a loss of USD 71 million for the first half of 2024. The profit was due to a higher adjusted operating profit and lower tax and financial expenses.

 
                                          Estimated 
Adjusted net profit (loss)              First Half 2025  First Half 2024 
Net profit (loss) attributable to 
 shareholders (USD millions)                47-54             (71) 
Earnings per share $(USD)$                0.0202-0.0234       (0.0303) 
-------------------------------------  ----------------  --------------- 
Net profit (loss) attributable to 
 shareholders (RMB millions)               337-391            (501) 
Earnings per share (RMB)                0.1446-0.1677       (0.2152) 
-------------------------------------  ----------------  --------------- 
 

Adjusted Net profit excludes the impact of transitory, non-operational or non-cash items, mainly including:

i. Non-cash amortization charges in respect of transfer assets received from Syngenta related to the 2017 ChemChina-Syngenta acquisition;

ii. Non-cash amortization net charges related to intangible assets created as part of the Purchase Price Allocation $(PPA)$ on acquisitions, with no impact on the ongoing performance of the companies acquired;

iii. Restructuring and advisory costs incurred as part of the continued implementation of the Fight Forward transformation plan;

iv. Provision of remediation costs by an indirectly wholly owned subsidiary of the Company for its plant in Israel;

v. Financial expenses including losses from repurchase of debentures at a premium by a wholly controlled subsidiary of the Company.

Reported EBITDA and Net Loss

The Company expects a higher reported EBITDA and its margin and a narrowed reported net loss (which include the impact of the above adjusted items) for the first half of 2025 compared to 2024. This expectation is mainly due to higher reported operating profit and lower tax expenses despite an increase in financial expenses.

 
                                          Estimated 
Reported net profit (loss)             First Half 2025   First Half 2024 
Net loss attributable to 
 shareholders (USD millions)              (15)-(7)            (126) 
Earnings per share $(USD.AU)$              (0.0064)-(0.0032)     (0.0541) 
------------------------------------  -----------------  --------------- 
Net loss attributable to 
 shareholders (RMB millions)             (108)-(54)           (895) 
Earnings per share (RMB)              (0.0464)-(0.0232)     (0.3841) 
------------------------------------  -----------------  --------------- 
 

The estimated results of the Company are a preliminary estimation of the Company and have not been audited or reviewed by certified accountants. However, the Company and the external auditor have preliminarily communicated regarding relevant matters of the performance estimation and have no material disagreement. These estimations may change as a result of the further processing and analysis of the financial data that the Company will perform for the preparation of its financial statements, which are expected to be released after trading hours on August 26, 2025.

Investors are reminded to exercise caution when making investment decisions.

About ADAMA

ADAMA Ltd. is a global leader in crop protection, providing practical solutions to farmers across the world to combat weeds, insects and disease. Our culture empowers ADAMA's people to actively listen to farmers and ideate from the field. ADAMA's diverse portfolio of existing active ingredients, coupled with its leading formulation capabilities and proprietary formulation technology platforms, uniquely position the company to develop high-quality, innovative and sustainable products, to address the many challenges farmers and customers face today. ADAMA serves customers in dozens of countries globally, with direct presence in all top 20 markets. For more information, visit us at www.ADAMA.com and follow us on X at @ADAMAAgri.

 
Contact 
Joshua Phillipson          Zhujun Wang 
Global Investor Relations  China Investor Relations 
Email: ir@adama.com        Email: irchina@adama.com 
 

Logo: https://mma.prnewswire.com/media/799829/Adama_Agricultural_Solutions_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/adama-provides-financial-performance-estimation-for-the-first-half-of-2025-302504236.html

SOURCE ADAMA Ltd.

 

(END) Dow Jones Newswires

July 14, 2025 07:40 ET (11:40 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10